Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 7-(1-ethylheptyl)-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl-
|
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 7-(1-ethylheptyl)-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl- Eigenschaften
- Dichte
- 1.29±0.1 g/cm3(Predicted)
- pka
- 9.94±0.20(Predicted)
Sicherheit
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 7-(1-ethylheptyl)-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl- Chemische Eigenschaften,Einsatz,Produktion Methoden
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 7-(1-ethylheptyl)-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 7-(1-ethylheptyl)-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 5)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Guangzhou CATO Research Chemicals Inc. | +86-020-81960175-617 +8615602392859 |
Intermediate@cato-chem.com | China | 6335 | 58 |
Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 |
3003392093@qq.com | China | 8790 | 55 |
Shanghai YuZn Pharm. Technology Co.,Ltd. | 15921286451; 15921286451 |
2010681527@qq.com | China | 5118 | 58 |
guoyungurui | 18162595016; 18162595016 |
3287908757@qq.com | China | 10335 | 58 |
Cato Research Chemicals Inc. | 13342851930 |
3008394369@qq.com | China | 15726 | 58 |
- Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 7-(1-ethylheptyl)-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl-
- Vardenafil Impurity 32
- Haloxyfop Impurity 7
- 252672-65-4